/CHM
CHM
Updated 20 Nov 06:33 am
$0.003
CHIMERIC THERAPEUTICS LIMITED
1D0.00%
1M0.00%
1Y-98.80%
Track your position in CHM
Sign in to TradeLedgr to record trades in CHM (CHIMERIC THERAPEUTICS LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
30 Oct 2026 4:16 AM
Notification of cessation of securities - CHM9KB
Appendix 3H (Notification of cessation of securities)
29 Oct 2026 10:45 PM
Notice of Annual General Meeting/Proxy Form664KB
Web Cast
29 Oct 2026 6:13 AM
Quarterly Activities/Appendix 4C Cash Flow Report5659KB
Commitments Test Entity - First Quarter Activity Report
08 Oct 2026 5:19 AM
Ceasing to be a substantial holder from MFG151KB
Ceasing to be a substantial holder
06 Oct 2026 8:27 AM
Notice of initial substantial holder from MFG162KB
Becoming a substantial holder
Fundamentals
P/E Ratio
—
Div Yield
0.00%
EPS
$-0.6097
Avg Vol
—
52W High
$0.400
52W Low
$0.003
Company Profile
Chimeric is a biotechnology company developing a cancer cell therapy drug
Corporate WebsiteFinancial History
2026A
$-18.8M profit
$0.0M rev
2025A
$-10.4M profit
$4.0M rev
2024A
$-12.5M profit
$0.0M rev